Vitali Sintchenko Selected Research

Vitali Sintchenko Research Topics

Disease

18	Whooping Cough (Pertussis) 12/2023 - 06/2009
15	Infections 04/2024 - 07/2005
5	Tuberculosis (Tuberculoses) 10/2019 - 04/2010
4	COVID-19 05/2023 - 09/2020
3	Communicable Diseases (Infectious Diseases) 12/2023 - 01/2004
3	Pneumococcal Infections 11/2023 - 11/2018
3	Coinfection 01/2022 - 11/2015
3	Human Influenza (Influenza) 12/2020 - 09/2009
2	Sepsis (Septicemia) 11/2023 - 01/2011
2	Reinfection 12/2021 - 01/2018
2	Pneumonia (Pneumonitis) 10/2020 - 07/2007
2	Pulmonary Tuberculosis 03/2020 - 10/2019
1	Extensively Drug-Resistant Tuberculosis 12/2023
1	Pseudomonas Infections 10/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Salmonella Infections (Salmonellosis) 12/2020
1	Botulism 09/2015
1	Bacillary Dysentery (Shigellosis) 08/2015
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 09/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2011
1	Ventilator-Associated Pneumonia 01/2006

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 12/2023 - 01/2011
5	Acellular VaccinesIBA 12/2023 - 06/2009
4	Virulence Factors (Pathogenicity Factors)IBA 04/2024 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 07/2005
4	AntigensIBA 01/2021 - 01/2011
4	pertactin FDA Link 01/2020 - 04/2014
3	MacrolidesIBA 12/2023 - 12/2020
2	Antiviral Agents (Antivirals)IBA 05/2023 - 09/2009
2	AntibodiesIBA 01/2021 - 09/2020
2	Nucleic AcidsIBA 09/2020 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2018
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2011 - 04/2010
1	AzolesIBA 11/2023
1	SolutionsIBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	16S Ribosomal RNAIBA 01/2023
1	23S Ribosomal RNAIBA 10/2022
1	Erythromycin (Erycette)FDA LinkGeneric 10/2022
1	Subgenomic RNAIBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	NucleotidesIBA 12/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	beta-LactamsIBA 12/2020
1	Conjugate VaccinesIBA 10/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2020
1	Immunoglobulin A (IgA)IBA 09/2020
1	Immunoglobulin G (IgG)IBA 09/2020
1	Immunoglobulin M (IgM)IBA 09/2020
1	AcidsIBA 03/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Surface Antigens (Surface Antigen)IBA 01/2020
1	Pertussis ToxinIBA 01/2020
1	Methionine (L-Methionine)FDA Link 10/2019
1	AminopeptidasesIBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Interferon-gamma (Interferon, gamma)IBA 10/2019
1	IronIBA 12/2018
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 12/2018
1	Fimbriae Proteins (Pilin)IBA 12/2018
1	ChlorhexidineIBA 11/2018
1	Sulfates (Sulfates, Inorganic)IBA 01/2018
1	NeurotoxinsIBA 09/2015
1	incobotulinumtoxinA FDA Link 09/2015
1	Azithromycin (Zithromax)FDA LinkGeneric 08/2015
1	FluoroquinolonesIBA 09/2014
1	Iron Chelating AgentsIBA 02/2014
1	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2012
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2010
1	OligonucleotidesIBA 04/2010
1	Complement System Proteins (Complement)IBA 07/2007

Therapy/Procedure

4	Therapeutics 01/2021 - 09/2009
1	Drug Therapy (Chemotherapy) 12/2023
1	Incubators 01/2022
1	Operative Surgical Procedures 12/2018
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 12/2018
1	Retreatment 01/2017
1	Intravesical Administration 01/2011
1	Immunotherapy 01/2011
1	Critical Care (Surgical Intensive Care) 01/2004